SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Pozen: POZN
An SI Board Since December 2004
Posts SubjectMarks Bans Symbol
19 6 0 POZN
Emcee:  mopgcw Type:  Unmoderated
Introduction Market Data Compact
 Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
19People have an idea that an SPA is needed because of the difficult nature of getkenhott-8/4/2008
18No clue. c/b big program. Investors hate how long it takes to make good stuff keokalani'nui-8/3/2008
17>>POZEN Receives Initial FDA Response To PA32540 SPA Friday August 1, 4:05tuck-8/1/2008
16Baker filed for 1.77m. Was 1m 12/31.keokalani'nui-4/18/2008
15What? Nobody cares about POZN? Treximet(TM) (Sumatriptan and Naproxen Sodium) kenhott-4/16/2008
14POZN gets Class II review from FDA on Trexima: >>CHAPEL HILL, N.C.--(BUSItuck-11/1/2007
13Looks like the deal was adjusted and now more backend loaded then before. Maybe rkrw-9/7/2007
12POZEN Announces September 7, 2007 Webcast Friday September 7, 7:00 am ET CHAPELkenhott-9/7/2007
11Pozen and Glaxo's "Hamster Problem" With Trexima Posted By:Mike HDoc Bones-8/3/2007
10Notable Calls reviews handicapping of Trexima approval, and suggests tactics fortuck-7/16/2007
9(TM) (Sumatriptan/Naproxen Sodium) Superior Efficacy Data Published in JAMA ApLJM-4/3/2007
8Just caught the last word of the cc the timeline for Trexima launch is the same dr.praveen-12/13/2006
7Pozen Expects to Submit Revised Response to Trexima(TM) (Sumatriptan/Naproxen Soquidditch-12/13/2006
6Press Release Source: POZEN Inc.; GlaxoSmithKline New Data Show InvestigationalIRWIN JAMES FRANKEL-6/26/2006
508:11 POZN POZEN: Discussions at AHS confirm Trexima safety - Jefferies (6.73 IRWIN JAMES FRANKEL-6/26/2006
4POZEN Inc. and GlaxoSmithKline Report Receipt of Approvable Letter for InvestigaLJM-6/9/2006
3Forbes: No More Headaches? Andy Stone, 04.17.06, 6:00 AM ET New York - Will Trmopgcw-4/24/2006
2Pozen says migraine drug mets targets in trials Message 21251098Doc Bones-4/21/2005
1piper POZN :3Q In Line; Trexima Phase 3 On Track 2004-10-27 17:05 (New York) mopgcw-12/14/2004
 Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News